News for 'Sun Pharma'

Maharashtra FDA warns against THIS cough syrup

Maharashtra FDA warns against THIS cough syrup

Rediff.com6 Oct 2025

The Maharashtra Food and Drug Administration (FDA) on Monday appealed to the people to immediately stop the sale or use of a specific batch of Coldrif syrup, following child deaths in Madhya Pradesh and Rajasthan allegedly linked to the medicine.

Will Tata Sons Get RBI Relief?

Will Tata Sons Get RBI Relief?

Rediff.com24 Oct 2025

Tata Sons, now debt-free, has asked the RBI to drop its 'upper-layer NBFC' tag and allow it to stay private.

Indian pharma improves compliance with USFDA; fewer OAI cases in 2024

Indian pharma improves compliance with USFDA; fewer OAI cases in 2024

Rediff.com30 Dec 2024

Indian pharmaceutical companies have made major strides in adhering to stringent US Food and Drug Administration (USFDA) norms in 2024, with data suggesting a decline in the number of adverse classification outcomes of inspections across biologics, drugs, and devices. In 2023, the USFDA conducted 225 inspections, which led to 18 cases of Official Action Indicated (OAI) and 117 cases of Voluntary Action Indicated (VAI).

Sensex climbs 124 points; Nifty ends above 25K

Sensex climbs 124 points; Nifty ends above 25K

Rediff.com11 Sep 2025

Among Sensex firms, NTPC, Axis Bank, Power Grid, Bharti Airtel, Eternal and Sun Pharma were the major gainers. However, Infosys, Titan, UltraTech Cement and Hindustan Unilever were among the laggards.

Toxic cough syrup kills 2 more kids in MP, toll rises to 22

Toxic cough syrup kills 2 more kids in MP, toll rises to 22

Rediff.com9 Oct 2025

The death toll from contaminated cough syrup in Madhya Pradesh has risen to 22, with two more children succumbing to kidney infections. An investigation is underway, and arrests have been made.

Modi and Putin: Hug in airport, ride in car, dinner at 7, LKM

Modi and Putin: Hug in airport, ride in car, dinner at 7, LKM

Rediff.com5 Dec 2025

Russian President Vladimir Putin arrived in New Delhi for a two-day visit focused on strengthening ties with India, including defense cooperation and trade, amidst a changing geopolitical landscape.

How To Choose MFs Smartly

How To Choose MFs Smartly

Rediff.com3 Dec 2025

Investors who constantly hop between 'top-performing' funds often end up earning far lower returns than the very funds they invest in -- simply because they enter late and exit early. Best investors don't chase returns, they chase discipline, says Ramalingam Kalirajan.

Sensex falls 344 pts amid profit-taking, foreign fund outflows

Sensex falls 344 pts amid profit-taking, foreign fund outflows

Rediff.com24 Oct 2025

Among Sensex firms, Hindustan Unilever dropped the most by 3.20 per cent. UltraTech Cement, Kotak Mahindra Bank, Adani Ports, Titan, HDFC Bank and Axis Bank were also among the laggards. However, Bharti Airtel, ICICI Bank, Bharat Electronics and Sun Pharma were among the gainers.

Upper-teens EPS growth likely for Gland Pharma in next two financial yrs

Upper-teens EPS growth likely for Gland Pharma in next two financial yrs

Rediff.com13 Nov 2024

Gland Pharma beat muted expectations for Q2FY25. There was increased Ebitda (Earnings before interest, taxes, depreciation and amortisation) loss at Cenexi, the CRAM subsidiary. However, overall Ebitda margin was better than expectations at 21.1 per cent. But given two years of earnings decline in FY23 and FY24, the business may have bottomed and upper-teens EPS (earnings per share) growth looks possible over next two financial years.

Weak Q4 may be rare bitter pill for Sun Pharma

Weak Q4 may be rare bitter pill for Sun Pharma

Rediff.com31 May 2024

Sun Pharmaceutical Industries reported a 34 per cent year-on-year (Y-o-Y) jump in net profit to Rs 2,654.6 crore in Q4FY24.

Samvat 2082: Investors likely to see up to 15% returns from equities

Samvat 2082: Investors likely to see up to 15% returns from equities

Rediff.com5 Nov 2025

After a year of modest returns, equity investors may anticipate gains of 10-15 per cent in Samvat 2082, which began on October 21. Although valuations have moderated from their peaks a year earlier, they remain above long-term averages, potentially limiting sharp upsides.

Stock markets end marginally lower in volatile trade

Stock markets end marginally lower in volatile trade

Rediff.com29 Sep 2025

Among Sensex firms, Maruti, Axis Bank, Larsen & Toubro, ICICI Bank, Bharti Airtel, Infosys, Adani Ports and Hindustan Unilever were the laggards. However, Titan, State Bank of India, Eternal and Trent were among the major gainers.

600 Crore IPO Fees Light Up Diwali For I-Bankers

600 Crore IPO Fees Light Up Diwali For I-Bankers

Rediff.com24 Oct 2025

With several $500 million-plus deals in the pipeline -- including ICICI Prudential AMC, Lenskart, PhonePe, Groww, PhysicsWallah, Meesho, Pine Labs, and Zepto -- investment bankers look poised for another year of hefty bonuses in 2025.

Sensex falls 388 points; Adani stocks rally

Sensex falls 388 points; Adani stocks rally

Rediff.com19 Sep 2025

Among Sensex firms, HCL Tech, ICICI Bank, Titan, Trent, Kotak Mahindra Bank, Hindustan Unilever, Mahindra & Mahindra and HDFC Bank were the major laggards. However, Adani Ports, Bharti Airtel, SBI, NTPC and Sun Pharma were among the gainers.

J-K pharma student thrashed in Nagpur; Fadnavis's intervention sought

J-K pharma student thrashed in Nagpur; Fadnavis's intervention sought

Rediff.com29 Apr 2025

A student from Jammu and Kashmir studying at a pharmacy college in Nagpur was thrashed by a group of local residents, prompting police to investigate the incident. The student, who ruled out a hate motive, said he was attacked by "anti-social elements" after being questioned about his origin. The J&K Students Association has called for action against the perpetrators.

Sensex ends above 83K buoyed by US Fed rate cut

Sensex ends above 83K buoyed by US Fed rate cut

Rediff.com18 Sep 2025

Among Sensex firms, Eternal, Sun Pharma, Infosys, HDFC Bank, HCL Tech, Hindustan Unilever, Power Grid, ITC and Adani Ports were the major gainers. However, Tata Motors, Trent, Bajaj Finance and Asian Paints were among the laggards.

Weight Loss Drug Mounjaro Registers Rs 80 Cr Sales

Weight Loss Drug Mounjaro Registers Rs 80 Cr Sales

Rediff.com8 Oct 2025

The bumper rise is due to the rising demand for the drug and patients' gradual shift towards its higher dosage.

TN govt revokes license for Coldrif cough syrup; shuts down firm

TN govt revokes license for Coldrif cough syrup; shuts down firm

Rediff.com13 Oct 2025

The Enforcement Directorate (ED) raided premises linked to Sresan Pharmaceuticals, the manufacturer of Coldrif cough syrup linked to the deaths of children in Madhya Pradesh and Rajasthan, and top officials of the Tamil Nadu FDA as part of a money laundering investigation.

Steel industry flags price pressure from cheap imports

Steel industry flags price pressure from cheap imports

Rediff.com27 Oct 2025

Ahead of the key meeting called by the steel ministry with the industry captains on Monday to discuss the impact of rising steel imports, companies have raised the issue of cheaper 'substandard' inflows from China, Vietnam, and South Korea, saying they are setting the benchmark for domestic prices and squeezing the profitability of Indian producers.

Sensex climbs 398 points on buying in RIL, IT counters

Sensex climbs 398 points on buying in RIL, IT counters

Rediff.com9 Oct 2025

Among Sensex firms, Tata Steel, HCL Tech, UltraTech Cement, Bharat Electronics, Sun Pharma and Tata Consultancy Services were the major gainers. However, Axis Bank, Titan, Maruti and Tata Motors were among the laggards.

Trump lists India, China among 23 countries as major drug transits

Trump lists India, China among 23 countries as major drug transits

Rediff.com18 Sep 2025

United States President Donald Trump has named 23 countries as the major drug transit or major illicit drug-producing countries in a 'Presidential Determination' submitted to Congress.

Was killer cough syrup exported, asks WHO to India

Was killer cough syrup exported, asks WHO to India

Rediff.com9 Oct 2025

The WHO will take a call on issuing a 'Global Medical Products Alert' on the cough syrup, Coldrif, after receiving an official confirmation from authorities here. The agency issues such alerts for substandard and contaminated medicines.

Telangana plant explosion toll rises to 42; 8 still missing

Telangana plant explosion toll rises to 42; 8 still missing

Rediff.com6 Jul 2025

The toll in the Sigachi Industries' pharma plant explosion in Sangareddy district rose to 42, officials said on Sunday.

3 cough syrups have been recalled: India replies to WHO

3 cough syrups have been recalled: India replies to WHO

Rediff.com9 Oct 2025

India's drug regulator CDSCO has recalled three cough syrups and halted their production after the WHO raised concerns about potential contamination and links to child deaths. The WHO is investigating reports of pediatric illnesses and deaths in India potentially linked to contaminated syrups.

Factors that will drive the markets this week

Factors that will drive the markets this week

Rediff.com28 Sep 2025

Stock markets will be driven by RBI's interest rate decision, tariff-related developments, global trends and trading activity of foreign investors in this holiday-shortened week, analysts said.

Rajasthan govt bans cough syrup after children's deaths

Rajasthan govt bans cough syrup after children's deaths

Rediff.com2 Oct 2025

A generic cough syrup supplied to the Rajasthan government has been linked to the deaths of two children and others falling sick in the state, prompting authorities to ban 22 batches of the drug and order an inquiry.

Drugmakers look to fill Rs 600 cr Novo vacuum

Drugmakers look to fill Rs 600 cr Novo vacuum

Rediff.com25 Sep 2025

Indian drugmakers Eris Lifesciences, Wockhardt and Lupin are prepping to cash in when Danish company Novo Nordisk bows out of the human insulin pen market by the end of this year and creates an opportunity estimated to be worth Rs 600-800 crore in the domestic market. Some self-use disposable pens are pre-filled with insulin and others can be reused with new cartridges.

Pharma cos okay with QR codes to combat counterfeit drugs

Pharma cos okay with QR codes to combat counterfeit drugs

Rediff.com19 Jul 2024

As the Drugs Controller General of India (DCGI) is set to crack down on companies to ensure compliance with printing QR codes on top-selling brands to curb counterfeiting, top pharma companies say they welcome the regulator's mandate and that they are on track. They also view it as a positive step to ensure patient safety. Sheetal Arora, CEO of Mankind Pharmaceuticals, which has already adopted QR codes in 20 of their products, stated: "We strongly advocate for mandatory implementation of barcodes and QR codes on medicines as this initiative will not only protect patients but also strengthen the integrity of our healthcare system by reducing circulation of counterfeit drugs."

Sensex jumps 555 pts on value buying, strong GDP data

Sensex jumps 555 pts on value buying, strong GDP data

Rediff.com1 Sep 2025

Among Sensex firms, Mahindra & Mahindra, Tata Motors, Trent, Eternal, Asian Paints and Infosys were the major gainers. However, Sun Pharma, ITC, Hindustan Unilever and Titan were among the laggards.

Sensex, Nifty dive nearly 1% as HDFC Bank, RIL drag

Sensex, Nifty dive nearly 1% as HDFC Bank, RIL drag

Rediff.com22 Aug 2025

From the Sensex pack, Asian Paints, UltraTech Cement, Tata Steel, ITC, HCL Tech, Kotak Mahindra Bank, Adani Ports, Tata Consultancy Services, HDFC Bank and Tech Mahindra were among the major laggards. However, Mahindra & Mahindra, Maruti, Bharat Electronics and Sun Pharma were among the gainers.

Bulls prowl D-Street: Sensex jumps 716 points

Bulls prowl D-Street: Sensex jumps 716 points

Rediff.com1 Oct 2025

From the Sensex firms, Tata Motors jumped the most by 5.54 per cent, followed by Kotak Mahindra Bank, Trent, Sun Pharma, Axis Bank, and ICICI Bank. However, Bajaj Finance, State Bank of India, UltraTech Cement and Tata Steel were among the laggards.

WHO issues alert against Indian cough syrups. They are...

WHO issues alert against Indian cough syrups. They are...

Rediff.com14 Oct 2025

The World Health Organisation (WHO) has issued an alert against three "substandard" oral cough syrups identified in India and urged national regulatory authorities worldwide to immediately notify it if these are detected in their country.

'We Have Become The Largest Eyewear Brand In Asia'

'We Have Become The Largest Eyewear Brand In Asia'

Rediff.com5 Nov 2025

'India needs at least 70,000 to 80,000 eyewear stores; our 2,000 stores are just a drop in the ocean.'

Sensex climbs 329 points on global markets' rally

Sensex climbs 329 points on global markets' rally

Rediff.com25 Aug 2025

From the Sensex firms, Infosys, Tata Consultancy Services, HCL Tech, Tech Mahindra, Tata Motors, Sun Pharma, Maruti and Titan were among the major gainers. Bharat Electronics, Asian Paints, Bharti Airtel and ICICI Bank were among the laggards.

Sun Pharma's growth pill: Specialising in specialty and scaling in India

Sun Pharma's growth pill: Specialising in specialty and scaling in India

Rediff.com25 Mar 2024

Traction for its specialty portfolio, a strong showing in the domestic market, and better regulatory compliance are positives for the country's largest pharmaceutical (pharma) company, Sun Pharmaceutical Industries. Given the triggers, some brokerages have increased their earnings per share estimates and target price for 2024-25 (FY25). This should sustain the momentum for the stock, which has been one of the major pharma gainers in 2023-24 (FY24), rising 57 per cent. It is currently trading at Rs 1,547 per share.

Indian pharma companies bank on 'mother brands' to boost revenue growth

Indian pharma companies bank on 'mother brands' to boost revenue growth

Rediff.com28 Mar 2024

Indian pharma companies are focussing on flagship products or mother brands under which they launch various new combinations to ensure robust revenue growth as well as therapy leadership. An analysis by market research firm Pharmarack showed how such flagship brands have posted strong growth CAGR in the last five years, with some even doubling sales. Sheetal Sapale, vice-president, commercial at Pharmarack, said, "Mother brands are analogous to an aggressive player who has put in a lot of effort during the prime years of life but now continues to silently nurture the brand family to collectively cross newer benchmarks of success."

Despite profit-booking, Sensex, Nifty end higher

Despite profit-booking, Sensex, Nifty end higher

Rediff.com8 Sep 2025

Among Sensex firms, Tata Motors rose the most by 3.97 per cent. Mahindra & Mahindra jumped by 3.96 per cent. Maruti, Adani Ports, Bajaj Finance and UltraTech Cement were also among the gainers. However, Trent declined 3.81 per cent. Asian Paints, HCL Tech, Tech Mahindra, L&T, TCS, Power Grid and Sun Pharma were also among the laggards.

Generic industry unlikely to be affected by Trump's EO: Indian drug cos

Generic industry unlikely to be affected by Trump's EO: Indian drug cos

Rediff.com14 May 2025

A fresh US executive order (EO) which seeks to bring down prices of prescription drugs in the country by up to 90 per cent -- on par with other developed nations -- will affect innovator companies, while sparing the Indian generic drug makers in the short term. US President Donald Trump signed the EO on Monday, directing the US Trade Representative and the Secretary of Commerce to act against foreign countries that "purposefully and unfairly undercut market prices", driving price hikes in the US.

Cough syrup deaths: MP minister blames Tamil Nadu govt

Cough syrup deaths: MP minister blames Tamil Nadu govt

Rediff.com8 Oct 2025

Madhya Pradesh minister Narendra Shivaji Patel blames the Tamil Nadu government for the deaths of 20 children due to contaminated cough syrup, citing negligence in inspecting medicines. The Tamil Nadu government has banned the sale of the syrup and ordered its removal from the market. Congress leader Digvijaya Singh criticizes the food and drug department's administration.

Sensex ends down 119 points on profit-taking in IT, auto shares

Sensex ends down 119 points on profit-taking in IT, auto shares

Rediff.com15 Sep 2025

Among Sensex firms, Mahindra & Mahindra, Asian Paints, Infosys, Titan, Sun Pharma, Tata Consultancy Services, Tech Mahindra and Power Grid were the major laggards. However, Bajaj Finance, Eternal, UltraTech Cement and Reliance Industries were among the gainers.